Search results
GSK says its experimental drug reduced asthma attacks with only two doses a year
Quartz· 3 days agoPeople suffering from a severe form of asthma could soon see their symptoms improve with a new...
Potential blockbuster asthma drug met goals in trials, GSK says
Morningstar· 3 days agoGSK on Tuesday said two late-stage trials of an asthma drug that could have peak sales of more than GBP3 billion ($3.8 billion) met their goals. GSK (GSK) (UK:GSK) said both ...
Too Few Asthma Patients Are Using Updated Inhalers
WFMZ Eastern Pennsylvania and Western New Jersey· 2 days agoImproved inhalers are now available to help control asthma and treat sudden attacks, but a new study shows that hardly anyone’s using them. The new...
GSK's experimental drug shows promise in reducing severe asthma attacks
AOL· 3 days agoThe drug, called depemokimab, showed "significant and meaningful reductions" in asthma attacks for patients with eosinophilic asthma, GSK said on Tuesday ...
GSK finds success in severe asthma drug trials
Becker’s Hospital Review· 3 days agoAfter positive results in phase 3 trials, a GSK experimental therapy could be the first ultra-long-acting biologic approved for severe asthma. The drug ...
Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
Zacks via Yahoo Finance· 21 hours agoGSK’s Study Data: GSK plc GSK announced its two late-stage studies on pipeline candidate depemokimab...
GSK says late-stage trials of potential blockbuster asthma drug met their goals
Market Watch· 3 days agoGSK on Tuesday said two late-stage trials of an asthma drug that could have peak sales of more than...
Illinois legislature passes bill to limit cost of inhalers to $25 a month
Chicago Tribune· 13 hours agoThe Illinois legislature has passed a bill that would cap patient costs for prescription inhalers at...
Heatwaves seem to be driving severe asthma flare-ups in children
New Scientist· 5 days agoHot weather appears to be triggering more frequent hospital visits for children with asthma. To...
GSK’s Potential Blockbuster Asthma Drug Shows Promise in Latest Trial
The Wall Street Journal· 3 days agoGSK said two late-stage trials of an asthma drug that could have peak sales of almost $4 billion met...
